Backgrounds
Methods
Data source and variables
Data preprocessing and case selection
Statistical analysis
Results
Demographic characteristics of the participants
Characteristics | Study A (78,319 cases) | Study B (74,121 cases) | ||||
---|---|---|---|---|---|---|
Jaundice group (366 cases) | Control group (77,953 cases) | p-value | Jaundice group (298 cases) | Control group (73,823 cases) | p-value | |
Agea (years) | 0.305 | 0.147 | ||||
15–24 | 20 (5.5) | 3,566 (4.6) | 12 (4.0) | 3,232 (4.4) | ||
25–34 | 294 (80.3) | 61,240 (78.6) | 247 (82.9) | 57,851 (78.4) | ||
35–49 | 52 (14.2) | 13,147 (16.9) | 39 (13.1) | 12,740 (17.3) | ||
Incomeb | 0.005* | 0.054 | ||||
1 (lowest) | 25 (6.8) | 8,221 (10.5) | 20 (6.7) | 7,645 (10.4) | ||
2 | 48 (13.1) | 12,553 (16.1) | 41 (13.8) | 11,627 (15.7) | ||
3 | 107 (29.2) | 20,567 (26.4) | 84 (28.2) | 19,465 (26.4) | ||
4 | 107 (29.2) | 24,046 (30.8) | 90 (30.2) | 23,065 (31.2) | ||
5 (highest) | 79 (21.6) | 12,566 (16.1) | 63 (21.1) | 12,021 (16.3) | ||
Preterm delivery | 5 (1.4) | 1,407 (1.8) | 0.693 | 2 (0.7) | 1,328 (1.8) | 0.187 |
Cesarean section | 181 (49.5) | 29,734 (38.1) | < 0.001* | 138 (46.3) | 27,998 (37.9) | < 0.001* |
Multiple gestation | 11 (3.0) | 1,156 (1.5) | 0.027* | 7 (2.3) | 1,073 (1.5) | 0.215 |
ANC duration | 211.50 ± 48.33 | 222.20 ± 35.94 | < 0.001* | 217.21 ± 41.29 | 221.75 ± 37.27 | 0.059 |
Characteristics | Study A (4,026 cases) | Study B (3,278 cases) | ||||
---|---|---|---|---|---|---|
Jaundice group (366 cases) | Control group (3,660 cases) | p-value | Jaundice group (298 cases) | Control group (2,980 cases) | p-value | |
Preterm delivery | 5 (1.4) | 66.00 (1.8) | 0.732 | 2 (0.7) | 52.17 (1.8) | 0.251 |
Cesarean section | 181 (49.5) | 1,376.70 (37.6) | < 0.001* | 138 (46.3) | 1,109.80 (37.2) | < 0.001* |
Multiple gestation | 11 (3.0) | 53.44 (1.5) | 0.047*a | 7 (2.3) | 42.85 (1.4) | 0.251b |
ANC duration | 211.50 ± 48.33 | 222.31 ± 36.01 | < 0.001* | 217.21 ± 41.29 | 222.16 ± 37.00 | 0.055c |
Odds ratios for each diagnosis code in the unmatched samples
Disease (diagnosis code) | Jaundice group (366 cases) | Control group (77,953 cases) | Unadjusted odds ratio (95% CI) | p-value* |
---|---|---|---|---|
Obstetrical tetanus (A34) | 1 (0.3) | 1 (0) | 212.33 (2.71–14,121.54) | 0.009 |
Other diseases of digestive system (K92) | 4 (1.1) | 86 (0.1) | 10.00 (2.65–26.79) | < 0.001 |
Alopecia areata (L63) | 2 (0.5) | 46 (0.1) | 9.31 (1.09–35.79) | 0.021 |
Other surgical follow-up care (Z48) | 6 (1.6) | 210 (0.3) | 6.17 (2.22–13.79) | < 0.001 |
Other and unspecified syphilis (A53) | 8 (2.2) | 370 (0.5) | 4.69 (1.99–9.43) | < 0.001 |
Leiomyoma of uterus (D25) | 11 (3.0) | 769 (1.0) | 3.11 (1.53–5.66) | 0.001 |
Infections of genitourinary tract in pregnancy (O23) | 29 (7.9) | 9,033 (11.6) | 0.66 (0.43–0.96) | 0.027 |
Acute nasopharyngitis (J00) | 22 (6.0) | 7,442 (9.5) | 0.61 (0.37–0.93) | 0.020 |
Acute upper respiratory infections of multiple and unspecified sites (J06) | 20 (5.5) | 7,041 (9.0) | 0.58 (0.35–0.91) | 0.017 |
Vasomotor and allergic rhinitis (J30) | 21 (5.7) | 7,593 (9.7) | 0.56 (0.34–0.88) | 0.008 |
Other functional intestinal disorders (K59) | 9 (2.5) | 3,755 (4.8) | 0.50 (0.23–0.96) | 0.036 |
Acute tonsillitis (J03) | 11 (3.0) | 4,773 (6.1) | 0.48 (0.23–0.86) | 0.011 |
Acute bronchitis (J20) | 12 (3.3) | 5,547 (7.1) | 0.44 (0.23–0.78) | 0.003 |
Gastritis and duodenitis (K29) | 13 (3.6) | 7,014 (9.0) | 0.37 (0.20–0.65) | < 0.001 |
Dyspepsia (K30) | 4 (1.1) | 2,491 (3.2) | 0.33 (0.09–0.87) | 0.016 |
Fever of other and unknown origin (R50) | 2 (0.5) | 1,820 (2.3) | 0.23 (0.03–0.84) | 0.015 |
Disease (diagnosis code) | Jaundice group (298 cases) | Control group (73,823 cases) | Unadjusted odds ratio (95% CI) | p-value* |
---|---|---|---|---|
Polyarteritis nodosa and related conditions (M30) | 1 (0.3) | 0 (0) | Inf (6.35-Inf) | 0.004 |
Disorders of glycoprotein metabolism (E77) | 1 (0.3) | 1 (0) | 248.76 (3.16–15,989.22) | 0.008 |
Acute and transient psychotic disorders (F23) | 1 (0.3) | 4 (0) | 62.11 (1.26–640.90) | 0.020 |
Other disorders of skin and subcutaneous tissue in diseases classified elsewhere (L99) | 1 (0.3) | 4 (0) | 62.11 (1.26–640.90) | 0.020 |
Family history of malignant neoplasm (Z80) | 1 (0.3) | 4 (0) | 62.11 (1.26–640.90) | 0.020 |
Paroxysmal tachycardia (I47) | 3 (1.0) | 73 (0.1) | 10.28 (2.06–31.51) | 0.004 |
Acute posthemorrhagic anemia (D62) | 3 (1.0) | 105 (0.1) | 7.14 (1.44–21.64) | 0.010 |
Respiratory tuberculosis, not confirmed bacteriologically or histologically (A16) | 4 (1.3) | 154 (0.2) | 6.51 (1.74–17.19) | 0.004 |
Other disorders of pigmentation (L81) | 3 (1.0) | 148 (0.2) | 5.06 (1.03–15.23) | 0.023 |
Alopecia areata (L63) | 5 (1.7) | 298 (0.4) | 4.21 (1.35–10.05) | 0.008 |
Other superficial mycoses (B36) | 5 (1.7) | 310 (0.4) | 4.05 (1.30–9.65) | 0.009 |
Anogenital herpes viral infection (A60) | 7 (2.3) | 541 (0.7) | 3.26 (1.29–6.85) | 0.007 |
Salpingitis and oophoritis (N70) | 10 (3.4) | 785 (1.1) | 3.23 (1.53–6.06) | 0.002 |
Urethritis and urethral syndrome (N34) | 7 (2.3) | 554 (0.8) | 3.18 (1.26–6.68) | 0.008 |
Eustachian salpingitis and obstruction (H68) | 8 (2.7) | 794 (1.1) | 2.54 (1.08–5.09) | 0.017 |
Acute bronchitis (J20) | 80 (26.8) | 23,856 (32.3) | 0.77 (0.59–1.00) | 0.047 |
Gastritis and duodenitis (K29) | 111 (37.2) | 33,027 (44.7) | 0.73 (0.57–0.93) | 0.010 |
Vasomotor and allergic rhinitis (J30) | 92 (30.9) | 29,922 (40.5) | 0.66 (0.51–0.84) | < 0.001 |
Dyspepsia (K30) | 35 (11.7) | 14,324 (19.4) | 0.55 (0.38–0.79) | < 0.001 |
Other disorders of nose and nasal sinuses (J34) | 7 (2.3) | 4,184 (5.7) | 0.40 (0.16–0.84) | 0.011 |
Other disorders of breast (N64) | 3 (1.0) | 2,221 (3.0) | 0.33 (0.07–0.97) | 0.040 |
Heartburn (R12) | 5 (1.7) | 4,209 (5.7) | 0.28 (0.09–0.67) | < 0.001 |
Pain associated with micturition (R30) | 0 (0) | 990 (1.3) | 0 (0–0.92) | 0.038 |
Risk and protective factors in the matched samples
Univariable | Multivariable | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Disease (diagnosis code) | Jaundice group | Control group | Unadjusted odds ratio (95% CI) | p-value* | Jaundice group | Control group | Adjusted odds ratio (95% CI) [p-value*] | ||||
Disease | Preterm | C-section | Multiple gestation | ANC duration | |||||||
Study A | 366 cases | 3,660 cases | 366 cases | 3,660 cases | |||||||
Other diseases of digestive system (K92) | 4 (1.1) | 3.80 (0.1) | 13.97 (2.21–238.30) | 0.004 | 4 (1.1) | 3.89 (0.1) | 14.12 (2.70–82.26) [0.003*] | 0.54 (0.21–1.38) [0.208] | 1.55 (1.24–1.93) [< 0.001*] | 1.60 (0.79–3.21) [0.234] | 0.99 (0.99–1.00) [< 0.001*] |
Other surgical follow-up care (Z48) | 6 (1.6) | 9.82 (0.3) | 6.96 (1.97–24.24) | 0.003 | 6 (1.6) | 9.82 (0.3) | 6.18 (2.09–18.53) [0.003*] | 0.53 (0.21–1.37) [0.200] | 1.51 (1.21–1.89) [< 0.001*] | 1.71 (0.86–3.40) [0.166] | 0.99 (0.99–1.00) [< 0.001*] |
Other and unspecified syphilis (A53) | 8 (2.2) | 17.52 (0.5) | 4.94 (1.81–12.47) | 0.002 | 8 (2.2) | 17.52 (0.5) | 5.24 (2.18–12.61) [< 0.001*] | 0.53 (0.21–1.37) [0.201] | 1.56 (1.25–1.95) [< 0.001*] | 1.69 (0.85–3.36) [0.177] | 0.99 (0.99–1.00) [< 0.001*] |
Leiomyoma of uterus (D25) | 11 (3.0) | 34.75 (0.9) | 3.32 (1.50–6.80) | 0.003 | 11 (3.0) | 34.77 (1.0) | 3.22 (1.59–6.52) [0.003*] | 0.53 (0.21–1.36) [0.198] | 1.54 (1.23–1.92) [< 0.001*] | 1.66 (0.83–3.30) [0.194] | 0.99 (0.99–1.00) [< 0.001*] |
Vasomotor and allergic rhinitis (J30) | 21 (5.7) | 357.13 (9.8) | 0.56 (0.34–0.89) | 0.014 | 21 (5.7) | 359.79 (9.8) | 0.58 (0.37–0.92) [0.024*] | 0.54 (0.21–1.38) [0.207] | 1.55 (1.24–1.94) [< 0.001*] | 1.67 (0.84–3.32) [0.187] | 0.99 (0.99–1.00) [< 0.001*] |
Acute tonsillitis (J03) | 11 (3.0) | 224.56 (6.1) | 0.48 (0.23–0.88) | 0.016 | 11 (3.0) | 226.83 (6.2) | 0.49 (0.26–0.91) [0.025*] | 0.53 (0.21–1.36) [0.197] | 1.55 (1.24–1.94) [< 0.001*] | 1.67 (0.84–3.32) [0.186] | 0.99 (0.99–1.00) [< 0.001*] |
Acute bronchitis (J20) | 12 (3.3) | 258.30 (7.1) | 0.45 (0.23–0.81) | 0.006 | 12 (3.3) | 258.49 (7.1) | 0.47 (0.26–0.84) [0.013*] | 0.53 (0.21–1.36) [0.198] | 1.55 (1.24–1.94) [< 0.001*] | 1.67 (0.84–3.31) [0.187] | 0.99 (0.99–1.00) [< 0.001*] |
Gastritis and duodenitis (K29) | 13 (3.6) | 326.31 (8.9) | 0.38 (0.20–0.66) | < 0.001 | 13 (3.6) | 326.31 (8.9) | 0.39 (0.22–0.69) [0.001*] | 0.53 (0.21–1.36) [0.199] | 1.55 (1.24–1.94) [< 0.001*] | 1.76 (0.88–3.50) [0.149] | 0.99 (0.99–1.00) [< 0.001*] |
Study B | 298 cases | 2,980 cases | 298 cases | 2,980 cases | |||||||
Salpingitis and oophoritis (N70) | 10 (3.4) | 31.30 (1.1) | 3.37 (1.45–7.20) | 0.005 | 10 (3.4) | 31.36 (1.1) | 3.33 (1.59–6.94) [0.003*] | 0.30 (0.07–1.27) [0.106] | 1.42 (1.11–1.82) [0.007*] | 1.47 (0.63–3.44) [0.421] | 1.00 (0.99–1.00) [0.051] |
Gastritis and duodenitis (K29) | 111 (37.2) | 1,332.70 (44.7) | 0.73 (0.57–0.94) | 0.017 | 111 (37.2) | 1,336.31 (44.8) | 0.75 (0.58–0.95) [0.023*] | 0.30 (0.07–1.28) [0.108] | 1.43 (1.12–1.83) [0.006*] | 1.53 (0.66–3.55) [0.372] | 1.00 (0.99–1.00) [0.092] |
Vasomotor and allergic rhinitis (J30) | 92 (30.9) | 1,210.73 (40.6) | 0.65 (0.50–0.85) | 0.002 | 92 (30.9) | 1,210.73 (40.6) | 0.66 (0.51–0.86) [0.003*] | 0.30 (0.07–1.27) [0.107] | 1.43 (1.12–1.83) [0.006*] | 1.53 (0.66–3.54) [0.376] | 1.00 (0.99–1.00) [0.102] |
Dyspepsia (K30) | 35 (11.7) | 576.78 (19.4) | 0.56 (0.37–0.80) | 0.001 | 35 (11.7) | 576.78 (19.4) | 0.56 (0.39–0.81) [0.003*] | 0.30 (0.07–1.28) [0.109] | 1.43 (1.12–1.83) [0.006*] | 1.57 (0.68–3.64) [0.347] | 1.00 (0.99–1.00) [0.093] |
Other disorders of nose and nasal sinuses (J34) | 7 (2.3) | 171.37 (5.8) | 0.40 (0.16–0.85) | 0.014 | 7 (2.3) | 172.14 (5.8) | 0.40 (0.19–0.87) [0.022*] | 0.30 (0.07–1.26) [0.104] | 1.42 (1.11–1.81) [0.007*] | 1.55 (0.67–3.59) [0.358] | 1.00 (0.99–1.00) [0.064] |
Heartburn (R12) | 5 (1.7) | 168.43 (5.7) | 0.29 (0.09–0.69) | 0.002 | 5 (1.7) | 168.43 (5.7) | 0.29 (0.12–0.71) [0.008*] | 0.30 (0.07–1.28) [0.108] | 1.43 (1.12–1.83) [0.006*] | 1.54 (0.67–3.57) [0.365] | 1.00 (0.99–1.00) [0.066] |